183 related articles for article (PubMed ID: 22383118)
1. Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial.
Jonas MM; Balistreri W; Gonzalez-Peralta RP; Haber B; Lobritto S; Mohan P; Molleston JP; Murray KF; Narkewicz MR; Rosenthal P; Schwarz KB; Barton BA; Shepherd JA; Mitchell PD; Duggan C
Hepatology; 2012 Aug; 56(2):523-31. PubMed ID: 22383118
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Follow-Up of Children Treated With Peginterferon and Ribavirin for Hepatitis C Virus Infection.
Haber B; Alonso E; Pedreira A; Rodriguez-Baez N; Ciocca M; Lacaille F; Lang T; Gonzalez T; Goodman Z; Yang Z; Jackson B; Noviello S; Albrecht JK
J Pediatr Gastroenterol Nutr; 2017 Jan; 64(1):89-94. PubMed ID: 27111344
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Combined Treatment with Pegylated Interferon Alpha-2b and Ribavirin for HCV Genotype 4 in Children.
El-Karaksy HM; Mogahed EA; El-Raziky MS; Saleh D; Besheer M; Mubarak S
J Interferon Cytokine Res; 2016 Jan; 36(1):1-8. PubMed ID: 26406390
[TBL] [Abstract][Full Text] [Related]
4. High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin.
Wirth S; Ribes-Koninckx C; Calzado MA; Bortolotti F; Zancan L; Jara P; Shelton M; Kerkar N; Galoppo M; Pedreira A; Rodriguez-Baez N; Ciocca M; Lachaux A; Lacaille F; Lang T; Kullmer U; Huber WD; Gonzalez T; Pollack H; Alonso E; Broue P; Ramakrishna J; Neigut D; Valle-Segarra AD; Hunter B; Goodman Z; Xu CR; Zheng H; Noviello S; Sniukiene V; Brass C; Albrecht JK
J Hepatol; 2010 Apr; 52(4):501-7. PubMed ID: 20189674
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic hepatitis C in children with pegylated interferon α2a and ribavirin--a multi-center study.
Słuzewski W; Kowala-Piaskowska A; Wysocki J; Figlerowicz M; Gorczyca A; Halota W; Jóźwiak H; Mizerski J; Mozer-Lisewska I; Pawłowska M; Rokitka M; Strawińska E; Szamotulska K
Acta Pol Pharm; 2012; 69(2):319-26. PubMed ID: 22568047
[TBL] [Abstract][Full Text] [Related]
6. Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
Liu CH; Huang CF; Liu CJ; Dai CY; Liang CC; Huang JF; Hung PH; Tsai HB; Tsai MK; Chen SI; Lin JW; Yang SS; Su TH; Yang HC; Chen PJ; Chen DS; Chuang WL; Yu ML; Kao JH
Ann Intern Med; 2013 Dec; 159(11):729-38. PubMed ID: 24297189
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of peginterferon alfa-2a and ribavirin treatment of chronic hepatitis C in the Republic of Serbia].
Božić M; Bojović K; Fabri M; Nožić D; Trkulja B; Milošević I
Srp Arh Celok Lek; 2012; 140(7-8):448-55. PubMed ID: 23092029
[TBL] [Abstract][Full Text] [Related]
8. Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects?
Gluhovschi C; Gadalean F; Kaycsa A; Curescu M; Sporea I; Gluhovschi G; Petrica L; Velciov S; Bozdog G; Bob F; Vernic C; Cioca D
Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):744-50. PubMed ID: 21320001
[TBL] [Abstract][Full Text] [Related]
9. Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: final results from the STEPS trial.
Shoeb D; Dearden J; Weatherall A; Bargery C; Moreea S; Alam S; White E; Vila X; Freshwater D; Ryder S; Mills PR; Alexander GJ; Forton D; Foster GR
J Hepatol; 2014 Apr; 60(4):699-705. PubMed ID: 24291239
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic hepatitis C genotype 1 early responders with 36 week pegylated interferon and ribavirin therapy.
Sood A; Midha V; Goyal O
Ann Hepatol; 2014; 13(5):503-9. PubMed ID: 25152982
[TBL] [Abstract][Full Text] [Related]
11. Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
Mousa N; Besheer T; Gad Y; Elbendary A; Mokbel T; Abdel-Aziz A
J Ocul Pharmacol Ther; 2013 Apr; 29(3):345-8. PubMed ID: 23113644
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus.
Tamai H; Shingaki N; Mori Y; Moribata K; Kawashima A; Maeda Y; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
Gut Liver; 2016 Jul; 10(4):617-23. PubMed ID: 26601828
[TBL] [Abstract][Full Text] [Related]
13. [Thyroid dysfunctions in children with chronic hepatitis C during interferon alpha-2b therapy].
Kupś-Rzepecka J; Woźniakowska-Gesicka T; Gołabek V
Przegl Lek; 2011; 68(6):311-5. PubMed ID: 22039668
[TBL] [Abstract][Full Text] [Related]
14. Taste disturbances during therapy with pegylated interferon-alpha 2b and ribavirin in patients with chronic hepatitis C.
Klimacka-Nawrot E; Musialik J; Suchecka W; Petelenz M; Hartman M; Lichtański P; Błońska-Fajfrowska B
Wiad Lek; 2010; 63(4):289-99. PubMed ID: 21608370
[TBL] [Abstract][Full Text] [Related]
15. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.
Serranti D; Indolfi G; Nebbia G; Cananzi M; D'Antiga L; Ricci S; Stagi S; Azzari C; Resti M;
Pediatr Infect Dis J; 2018 Apr; 37(4):287-291. PubMed ID: 28953189
[TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin.
Harrison SA; Hamzeh FM; Han J; Pandya PK; Sheikh MY; Vierling JM
Hepatology; 2012 Aug; 56(2):464-73. PubMed ID: 22334369
[TBL] [Abstract][Full Text] [Related]
17. The impact of combination therapy with peginterferon alpha-2a and ribavirin on the energy intake and body weight of adult hepatitis C patients.
Hamer C
J Hum Nutr Diet; 2008 Oct; 21(5):486-93. PubMed ID: 18647213
[TBL] [Abstract][Full Text] [Related]
18. Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.
Espinosa M; Hernàndez J; Arenas MD; Carnicer F; Caramelo C; Fabrizi F
Kidney Blood Press Res; 2015; 40(3):258-65. PubMed ID: 25997572
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of peginterferon alpha-2A and ribavirin combination therapy in treatment-naive Estonian patients with chronic hepatitis C.
Brjalin V; Salupere R; Tallo T; Kuznetsova T; Priimägi L; Tefanova V
Cent Eur J Public Health; 2012 Jun; 20(2):150-5. PubMed ID: 22966742
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of pegylated interferon-alpha2a plus ribavirin versus pegylated interferon-alpha2b plus ribavirin in treatment-naive chronic hepatitis C patients.
Lee S; Kim IH; Kim SH; Kim SW; Lee SO; Lee ST; Kim DG; Lee CS; Choi CS; Cho EY; Kim HC
Intervirology; 2010; 53(3):146-53. PubMed ID: 20068348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
